Clinical Trials Sponsored by MAC Clinical Research

Total 3805 results

Scottish Clinical Trials Research Unit
Pfizer

Completed

Study of Axitinib for Reducing Extent of Venous Tumour Thrombus in Renal Cancer With Venous Invasion (NAXIVA)

Renal Cell Carcinoma | Metastatic Renal Cell Carcinoma | Non-metastatic Renal Cell Carcinoma

United Kingdom
Clinical Research Center Kiel GmbH
Nofima

Completed

Glycemic Response to Low Sugar Apple Juice

Impaired Fasting Glucose

Germany
Swiss Group for Clinical Cancer Research

Completed

Radiation Therapy and Chemotherapy, With or Without Cetuximab, Followed by Surgery in Treating Patients With Locally Advanced Esophageal Cancer That Can Be Removed by Surgery

Esophageal Cancer | Adenocarcinoma of the Gastroesophageal Junction

Switzerland, France, Austria, Germany, Hungary
Trevena Inc.
Lotus Clinical Research, LLC

Completed

A Study of TRV130 for the Treatment of Pain After Abdominoplasty

Pain

United States
Swiss Group for Clinical Cancer Research

Completed

Early Hippocampal Avoidance Prophylactic Cranial Irradiation in Patients With LD SCLC

Small-Cell Lung Cancer

Switzerland
Golden Biotechnology Corporation
ICON Clinical Research

Completed

Efficacy, Safety and Pharmacokinetics Study of Antroquinonol to Treat NSCLC

Non-small Cell Lung Cancer Stage IV

United States, Taiwan
Swiss Group for Clinical Cancer Research

Completed

LDE225 and Paclitaxel in Solid Tumors

Ovarian Cancer | Solid Tumor

Switzerland
Scynexis, Inc.
ethica Clinical Research Inc.

Completed

Safety and Efficacy of Oral Ibrexafungerp (SCY-078) vs. Oral Fluconazole in Subjects With Vulvovaginal Candidiasis

Vulvovaginal Candidiasis

Dominican Republic
Swiss Group for Clinical Cancer Research

Completed

Capecitabine and Oxaliplatin in Treating Patients With Advanced or Metastatic Colorectal Cancer

Colorectal Cancer

Switzerland
Swiss Group for Clinical Cancer Research

Completed

Nelfinavir as Bortezomib-sensitizing Drug in Patients With Proteasome Inhibitor-nonresponsive Myeloma

Myeloma

Switzerland
Swiss Group for Clinical Cancer Research

Completed

Capecitabine in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy

Prostate Cancer

Switzerland
Swiss Group for Clinical Cancer Research

Completed

F511 Cream in Preventing Palmar-Plantar Erythrodysesthesia in Patients Receiving Doxorubicin Hydrochloride Liposome for Metastatic Breast Cancer

Breast Cancer | Palmar-plantar Erythrodysesthesia

Switzerland
Swiss Group for Clinical Cancer Research

Completed

Nelfinavir Mesylate and Bortezomib in Treating Patients With Relapsed or Progressive Advanced Hematologic Cancer

Lymphoma | Leukemia | Multiple Myeloma and Plasma Cell Neoplasm | Mature T-cell and Nk-cell Neoplasms

Switzerland
Swiss Group for Clinical Cancer Research

Completed

Melphalan, Yttrium Y 90 Ibritumomab Tiuxetan, and Rituximab Followed by Autologous Stem Cell Transplant in Treating Older Patients With Non-Hodgkin's Lymphoma That Has Relapsed or Not Responded to Previous Treatment

Lymphoma

Switzerland
Swiss Group for Clinical Cancer Research

Completed

Adjuvant Treatment Recommendation and Oncotype DX® in Early Breast Cancer

Breast Cancer

Switzerland
Swiss Group for Clinical Cancer Research

Completed

Impact of a Surgical Sealing Patch on Lymphatic Drainage After ALND for Breast Cancer

Breast Cancer

Switzerland
Swiss Group for Clinical Cancer Research

Completed

E-MOSAIC Electronic Tool to Monitor Symptoms

Cancer

Switzerland
Swiss Group for Clinical Cancer Research

Completed

Bevacizumab, Pemetrexed Disodium, and Cisplatin or Erlotinib Hydrochloride and Bevacizumab in Treating Patients With Stage IV Non-Small Cell Lung Cancer. A Multicenter Phase II Trial Including Biopsy at Progression (BIO-PRO Trial).

Lung Cancer

Switzerland
Swiss Group for Clinical Cancer Research

Completed

Radiation Therapy With or Without Cisplatin in Treating Patients With Advanced Head and Neck Cancer

Head and Neck Cancer

Switzerland
Swiss Group for Clinical Cancer Research

Completed

Chemosensitivity Testing to Assign Treatment for Patients With Stage III or Stage IV Ovarian Cancer

Ovarian Cancer

Switzerland
Swiss Group for Clinical Cancer Research

Completed

Rectal Reconstruction in Treating Patients Who Are Undergoing Surgery for Rectal Cancer

Colorectal Cancer

Switzerland, Germany
Swiss Group for Clinical Cancer Research

Completed

External-Beam Radiation Therapy, Capecitabine, and Sorafenib in Treating Patients With Locally Advanced Rectal Cancer

Colorectal Cancer

Switzerland, Hungary
Swiss Group for Clinical Cancer Research

Completed

Monoclonal Antibody Therapy in Treating Patients With Follicular or Mantle Cell Lymphoma

Lymphoma

Switzerland
Swiss Group for Clinical Cancer Research

Completed

Combination Chemotherapy Followed by Surgery in Treating Patients With Non-small Cell Lung Cancer

Lung Cancer

Switzerland
Swiss Group for Clinical Cancer Research

Completed

Rituximab in Treating Patients With Follicular Non-Hodgkin's Lymphoma

Lymphoma

Switzerland, South Africa, Italy, Brazil, North Macedonia, Serbia, Slovakia
Swiss Group for Clinical Cancer Research

Completed

Docetaxel and Cetuximab in Treating Patients With Metastatic Prostate Cancer

Prostate Cancer

Switzerland
Edwards Lifesciences
Pacific Clinical Research Group

Completed

The SOLACE-AU Clinical Trial (SOLACE-AU)

Severe, Symptomatic Aortic Stenosis

Australia
Atridia Pty Ltd.
Linear Clinical Research

Completed

A Single Dose Study of SHR0410 in Healthy Male Participants

Acute Pain

Australia
Bühlmann Laboratories AG
ICON Clinical Research

Completed

BÜHLMANN fCAL™ ELISA - Aid in Differentiation of IBD From IBS

Irritable Bowel Syndrome | Inflammatory Bowel Disease

United States
Epidemiological and Clinical Research Information...

Completed

A Phase III Study of 2nd-line XELIRI ± Bevacizumab vs. FOLFIRI ± Bevacizumab in mCRC (AXEPT)

Gastrointestinal Neoplasms | Digestive System Neoplasms | Neoplasm Metastasis | Colorectal Neoplasms | Intestinal Neoplasms

Japan
AGA Clinical Research Associates, LLC
Takeda

Terminated

Vedolizumab Induction May Prevent Celiac Enteritis

Celiac Disease

United States
Teoxane SA
ethica Clinical Research Inc.

Completed

TEOSYAL® RHA Ultra Deep and Perlane-L® for the Correction of Nasolabial Folds

Nasolabial Folds, Wrinkles

United States
RAI Services Company
Davita Clinical Research

Completed

CSD170303: Study to Assess Nicotine Uptake in Smokers From Electronic Cigarettes

Smoking

United States
RAI Services Company
Davita Clinical Research

Completed

CSD170302: Study to Assess Nicotine Uptake in Smokers From Electronic Cigarettes

Smoking

United States
RAI Services Company
Davita Clinical Research

Completed

CSD1602: A Crossover Study to Evaluate the Exposure to "Tar" and Nicotine From Two King Size Menthol Cigarette Products

Smoking

United States
RAI Services Company
Davita Clinical Research

Completed

CSD1603: A Crossover Study to Evaluate the Exposure to "Tar" and Nicotine From 100s Menthol Cigarette Products

Smoking

United States
Davita Clinical Research
Baxter Healthcare Corporation

Terminated

Adjuvant Peritoneal Dialysis on a Background of Thrice-Weekly Hemodialysis

Functionally Anuric | Hemodialysis/Peritoneal Dialysis
European Vision Institute Clinical Research Network

Completed

Project Gullstrand - European Project for the Determination of Average Biometric Values of Human Eyes (Gullstrand)

Normal Subjects, Ametropia

Spain
HeartFlow, Inc.
Duke Clinical Research Institute

Completed

The PLATFORM Study: Prospective LongitudinAl Trial of FFRct: Outcome and Resource IMpacts) (PLATFORM)

Coronary Artery Disease

United States, Germany, United Kingdom, Denmark, Belgium, Austria, France, Italy
Fresenius Kabi
Institute for Clinical Research

Completed

Intradialytic Parenteral Nutrition in Hemodialysis Patients (IDPNHD)

Malnutrition | Complication of Hemodialysis

Germany
Clinical Oncology Research Associates
Aventis Pharmaceuticals

Completed

Once Weekly Radiation for Lung Cancer With Chemotherapy

Carcinoma, Non-Small-Cell Lung

United States
Swiss Group for Clinical Cancer Research

Completed

Paclitaxel, Carboplatin, and Dimethylxanthenone Acetic Acid in Treating Patients With Extensive-Stage Small Cell Lung Cancer

Lung Cancer

Switzerland
Swiss Group for Clinical Cancer Research

Completed

Bevacizumab and Doxorubicin Hydrochloride Liposome in Treating Women With Locally Recurrent or Metastatic Breast Cancer

Breast Cancer

Switzerland
Swiss Group for Clinical Cancer Research

Completed

Sunitinib in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery

Liver Cancer

Switzerland
Swiss Group for Clinical Cancer Research

Completed

Cetuximab, Docetaxel, Cisplatin, and Radiation Therapy in Treating Patients With Locally Advanced Esophageal Cancer That Can Be Removed by Surgery

Esophageal Cancer

Switzerland
Swiss Group for Clinical Cancer Research

Completed

Gefitinib as First-Line Therapy Followed by Gemcitabine and Cisplatin in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer

Lung Cancer

Switzerland
Swiss Group for Clinical Cancer Research

Completed

Combination Chemotherapy Before Surgery in Treating Patients With Mesothelioma of the Lung

Malignant Mesothelioma

Switzerland
Swiss Group for Clinical Cancer Research

Completed

Combination Chemotherapy in Treating Patients With Advanced Stomach Cancer

Gastric Cancer

Switzerland
Swiss Group for Clinical Cancer Research

Completed

Cladribine and Rituximab as Remission Induction Therapy Followed By Rituximab and Stem Cell Mobilization in Treating Patients With CLL

Leukemia

Switzerland
American Scitech International
Proactive Clinical Research

Unknown

Evaluate the Side Effects and Benefits of RAS 130 With or Without Diet and Exercise in Type II Diabetes Mellitus (ASI-DMII)

Type II Diabetes Mellitus

United States, India

Clinical Trials Sponsored by MAC Clinical Research

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Pakistan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations